Want to see FR:BLC full AI Analyst Report?
Top Page
Bastide le Confort Medical
(BLC)
Select Model
Select Model
Rating:49Neutral
Price Target:
€27.00
▲(13.21% Upside)
Action:Reiterated
Date:12/11/25
The overall stock score is primarily impacted by financial performance challenges, including high leverage and declining revenue growth. Technical analysis indicates bearish momentum, and the stock appears overvalued based on its P/E ratio. These factors collectively result in a lower score.
Positive Factors
High gross & EBITDA margins
Sustained high gross (≈68%) and EBITDA (20.8%) margins reflect durable operational efficiency and pricing power in device distribution and services. These margins provide a structural cushion against revenue volatility, support reinvestment in network and services, and help preserve cash generation even if top-line growth slows.
Negative Factors
Declining revenue growth
A sustained decline in revenue (reported -9.1%) erodes scale benefits and pressures fixed-cost absorption. Over months this reduces leverage on strong gross margins, constrains capacity to invest in branches or services, and raises the bar for management to restore organic growth or offset with acquisitions.
Read all positive and negative factors
Positive Factors
Negative Factors
High gross & EBITDA margins
Sustained high gross (≈68%) and EBITDA (20.8%) margins reflect durable operational efficiency and pricing power in device distribution and services. These margins provide a structural cushion against revenue volatility, support reinvestment in network and services, and help preserve cash generation even if top-line growth slows.
Read all positive factors
Bastide le Confort Medical (BLC) vs. iShares MSCI France ETF (EWQ)
Market Cap
€177.34M
Dividend YieldN/A
Average Volume (3M)5.76K
Price to Earnings (P/E)5.9
Beta (1Y)0.71
Revenue Growth-11.89%
EPS Growth1623.56%
CountryFR
Employees3,635
SectorGeneral
Sector StrengthN/A
IndustryMedical - Equipment & Services
Share Statistics
EPS (TTM)4.00
Shares Outstanding7,365,078
10 Day Avg. Volume5,209
30 Day Avg. Volume5,758
Financial Highlights & Ratios
PEG Ratio-2.76
Price to Book (P/B)3.24
Price to Sales (P/S)0.48
P/FCF Ratio5.60
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)2.12
Revenue Forecast (FY)€540.00M
Bastide le Confort Medical Business Overview & Revenue Model
Company Description
Bastide Le Confort Médical SA specializes in the provision, through both sales and rentals, of medical equipment across France. The company offers a comprehensive array of items, encompassing comfort and wellness products such as specialized seati...
How the Company Makes Money
BLC makes money primarily by selling, renting, and servicing home medical equipment and by providing homecare-related services. Key revenue streams typically include: (1) recurring revenue from the rental of medical devices used over long periods ...
Bastide le Confort Medical Financial Statement Overview
Summary
Income Statement
65
Positive
Balance Sheet
50
Neutral
Cash Flow
70
Positive
| Breakdown | TTM | Sep 2025 | Sep 2024 | Jun 2023 | Sep 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 476.02M | 491.18M | 529.75M | 508.03M | 468.30M | 444.07M |
| Gross Profit | 49.09M | 333.00M | 354.44M | 333.73M | 306.80M | 280.26M |
| EBITDA | 98.75M | 102.03M | 107.20M | 98.15M | 89.83M | 88.30M |
| Net Income | 29.45M | 528.00K | -900.00K | 12.05M | 13.68M | 13.45M |
Balance Sheet | ||||||
| Total Assets | 580.52M | 661.03M | 647.07M | 657.08M | 632.55M | 569.11M |
| Cash, Cash Equivalents and Short-Term Investments | 25.47M | 25.49M | 23.62M | 36.71M | 22.13M | 33.74M |
| Total Debt | 324.13M | 411.16M | 408.65M | 427.39M | 419.23M | 357.62M |
| Total Liabilities | 478.08M | 589.73M | 566.34M | 568.99M | 545.89M | 484.05M |
| Stockholders Equity | 102.75M | 72.13M | 79.77M | 87.65M | 84.56M | 81.31M |
Cash Flow | ||||||
| Free Cash Flow | 29.93M | 41.74M | 10.64M | 36.65M | -6.51M | 19.62M |
| Operating Cash Flow | 78.98M | 101.82M | 66.04M | 90.28M | 46.76M | 66.13M |
| Investing Cash Flow | 27.86M | -56.44M | -43.65M | -76.27M | -104.74M | -73.45M |
| Financing Cash Flow | -102.88M | -4.33M | -35.55M | -7.89M | 29.43M | 1.34M |
Bastide le Confort Medical Technical Analysis
Neutral
23.85
Price Trends
25.12
Negative
24.86
Negative
24.70
Negative
Market Momentum
-0.31
Negative
50.42
Neutral
41.67
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FR:BLC, the sentiment is Neutral. The current price of 23.85 is above the 20-day moving average (MA) of 23.73, below the 50-day MA of 25.12, and below the 200-day MA of 24.70, indicating a neutral trend. The MACD of -0.31 indicates Negative momentum. The RSI at 50.42 is Neutral, neither overbought nor oversold. The STOCH value of 41.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for FR:BLC.
Bastide le Confort Medical Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | €114.84B | 29.51 | 13.87% | 2.06% | -0.43% | 6.33% | |
68 Neutral | €481.76M | 14.84 | 5.18% | 3.95% | 2.78% | 187.96% | |
61 Neutral | €8.23B | 20.95 | 9.69% | 0.82% | 2.26% | -8.10% | |
60 Neutral | €144.55M | -9.79 | -5.44% | ― | -0.81% | ― | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
49 Neutral | €177.34M | 5.92 | 3.97% | ― | -11.89% | 1623.56% | |
40 Underperform | €66.54M | -3.20 | -16.98% | ― | 4.22% | 80.11% |
* General Sector Average
FR:BLC
Bastide le Confort Medical
24.25
-7.80
-24.34%
FR:AI
Air Liquide
180.30
24.19
15.50%
FR:BIM
bioMerieux
69.70
-47.88
-40.72%
FR:BOI
Boiron SA
27.50
5.92
27.41%
FR:ALCGM
Cegedim
10.54
-0.31
-2.86%
FR:VTR
Vitura SA
3.90
-2.30
-37.10%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.